Glaukos Future Growth

Future criteria checks 2/6

Glaukos is forecast to grow earnings and revenue by 69.5% and 20.7% per annum respectively. EPS is expected to grow by 71.7% per annum. Return on equity is forecast to be -5.4% in 3 years.

Key information

69.5%

Earnings growth rate

71.7%

EPS growth rate

Medical Equipment earnings growth12.9%
Revenue growth rate20.7%
Future return on equity-5.4%
Analyst coverage

Good

Last updated28 Jan 2025

Recent future growth updates

Glaukos Corporation (NYSE:GKOS) Just Reported And Analysts Have Been Lifting Their Price Targets

Aug 07
Glaukos Corporation (NYSE:GKOS) Just Reported And Analysts Have Been Lifting Their Price Targets

Recent updates

Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?

Jan 17
Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?

Are Investors Undervaluing Glaukos Corporation (NYSE:GKOS) By 50%?

Dec 25
Are Investors Undervaluing Glaukos Corporation (NYSE:GKOS) By 50%?

Glaukos: Still Bullish, But Embedded Expectations Are Now High

Dec 21

Revenues Tell The Story For Glaukos Corporation (NYSE:GKOS)

Dec 03
Revenues Tell The Story For Glaukos Corporation (NYSE:GKOS)

Is Glaukos (NYSE:GKOS) Using Debt In A Risky Way?

Sep 18
Is Glaukos (NYSE:GKOS) Using Debt In A Risky Way?

Glaukos Corporation: Ripe For Some Consolidation

Sep 11

Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 81% Above Its Share Price

Aug 28
Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 81% Above Its Share Price

Glaukos Corporation (NYSE:GKOS) Just Reported And Analysts Have Been Lifting Their Price Targets

Aug 07
Glaukos Corporation (NYSE:GKOS) Just Reported And Analysts Have Been Lifting Their Price Targets

Glaukos Corporation's (NYSE:GKOS) Popularity With Investors Is Clear

Jul 18
Glaukos Corporation's (NYSE:GKOS) Popularity With Investors Is Clear

Glaukos (NYSE:GKOS) Is Carrying A Fair Bit Of Debt

Jun 11
Glaukos (NYSE:GKOS) Is Carrying A Fair Bit Of Debt

Glaukos Stock: Still Unproven Whether A New Bull Market Has Begun

May 30

Here's Why Glaukos Corporation's (NYSE:GKOS) CEO Compensation Is The Least Of Shareholders' Concerns

May 24
Here's Why Glaukos Corporation's (NYSE:GKOS) CEO Compensation Is The Least Of Shareholders' Concerns

Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching

Apr 22
Why Glaukos Corporation (NYSE:GKOS) Could Be Worth Watching

Glaukos Corporation (NYSE:GKOS) Not Lagging Industry On Growth Or Pricing

Apr 04
Glaukos Corporation (NYSE:GKOS) Not Lagging Industry On Growth Or Pricing

Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 69% Above Its Share Price

Feb 21
Glaukos Corporation's (NYSE:GKOS) Intrinsic Value Is Potentially 69% Above Its Share Price

Glaukos: Remains A Hold Due To High Valuation And Negative Profitability

Jan 09

Glaukos: Continued Growth Rates, Regulatory Tailwinds, And Support

Sep 01

Glaukos: Revising To Buy On These 3 Catalytic Factors

Jun 16

Glaukos: Trial Momentum Building, Profitability Differentials Yet To Pull Through

Feb 14

Glaukos sees positive data from mid-stage trial of dry eye treatment

Jan 10

Glaukos: Show Me The Money

Nov 10

Earnings and Revenue Growth Forecasts

NYSE:GKOS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20277454N/AN/A2
12/31/2026608-27849912
12/31/2025479-6922914
12/31/2024379-141-35-2014
9/30/2024360-150-81-72N/A
6/30/2024342-159-82-71N/A
3/31/2024326-141-75-61N/A
12/31/2023315-135-78-58N/A
9/30/2023304-129-75-51N/A
6/30/2023297-126-97-70N/A
3/31/2023289-139-104-74N/A
12/31/2022283-99-63-33N/A
9/30/2022285-90-65-34N/A
6/30/2022288-56-2511N/A
3/31/2022294-28-730N/A
12/31/2021294-50-2325N/A
9/30/2021294-38-140N/A
6/30/2021284-60-1913N/A
3/31/2021238-83-29-6N/A
12/31/2020225-120-30-23N/A
9/30/2020218-73-44-38N/A
6/30/2020211-71-37-31N/A
3/31/2020238-37-19-14N/A
12/31/201923715-50N/A
9/30/2019225-191021N/A
6/30/2019211-121728N/A
3/31/2019195-121626N/A
12/31/2018181-13919N/A
9/30/2018169-141014N/A
6/30/2018165-6N/A17N/A
3/31/2018163-4N/A17N/A
12/31/20171590N/A26N/A
9/30/2017151-1N/A17N/A
6/30/2017140-1N/A14N/A
3/31/20171275N/A16N/A
12/31/20161145N/A12N/A
9/30/20161022N/A8N/A
6/30/201691-1N/A4N/A
3/31/201680-35N/A-2N/A
12/31/201572-37N/A-2N/A
9/30/201566-40N/A-3N/A
6/30/201559-39N/A-2N/A
3/31/201552-9N/A-3N/A
12/31/201446-12N/A-7N/A
9/30/201438-11N/A-8N/A
6/30/201433-12N/A-10N/A
3/31/201426-13N/A-13N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GKOS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: GKOS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: GKOS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: GKOS's revenue (20.7% per year) is forecast to grow faster than the US market (8.8% per year).

High Growth Revenue: GKOS's revenue (20.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GKOS is forecast to be unprofitable in 3 years.


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 02:14
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Glaukos Corporation is covered by 25 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Ravi MisraBerenberg
Joanne WuenschBMO Capital Markets Equity Research